Show simple item record

dc.contributor.authorChick, J
dc.contributor.authorAlexander, S
dc.contributor.authorHerbert, T
dc.contributor.authorHuddart, R
dc.contributor.authorIngle, M
dc.contributor.authorMitchell, A
dc.contributor.authorNill, S
dc.contributor.authorOelfke, U
dc.contributor.authorDunlop, A
dc.contributor.authorHafeez, S
dc.coverage.spatialNetherlands
dc.date.accessioned2023-09-26T10:08:57Z
dc.date.available2023-09-26T10:08:57Z
dc.date.issued2023-07-01
dc.identifier100481
dc.identifierS2405-6316(23)00072-6
dc.identifier.citationPhysics and Imaging in Radiation Oncology, 2023, 27 pp. 100481 -
dc.identifier.issn2405-6316
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5988
dc.identifier.eissn2405-6316
dc.identifier.eissn2405-6316
dc.identifier.doi10.1016/j.phro.2023.100481
dc.description.abstractHybrid systems that combine Magnetic Resonance Imaging (MRI) and linear accelerators are available clinically to guide and adapt radiotherapy. Vendor-approved MRI sequences are provided, however alternative sequences may offer advantages. The aim of this study was to develop a systematic approach for non-vendor sequence evaluation, to determine safety, accuracy and overall clinical application of two potential sequences for bladder cancer MRI guided radiotherapy. Non-vendor sequences underwent and passed clinical image qualitative review, phantom quality assurance, and radiotherapy planning assessments. Volunteer workflow tests showed the potential for one sequence to reduce workflow time by 27% compared to the standard vendor sequence.
dc.formatElectronic-eCollection
dc.format.extent100481 -
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER
dc.relation.ispartofPhysics and Imaging in Radiation Oncology
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAdaptive radiotherapy
dc.subjectBladder cancer
dc.subjectMRI guided radiotherapy
dc.subjectMRI sequence evaluation
dc.subjectNon-vendor sequences
dc.subjectQuality assurance
dc.titleEvaluation of non-vendor magnetic resonance imaging sequences for use in bladder cancer magnetic resonance image guided radiotherapy.
dc.typeJournal Article
dcterms.dateAccepted2023-08-11
dc.date.updated2023-09-26T10:08:13Z
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1016/j.phro.2023.100481
rioxxterms.licenseref.startdate2023-07-01
rioxxterms.typeJournal Article/Review
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/37655122
pubs.organisational-groupICR
pubs.organisational-groupICR/Primary Group
pubs.organisational-groupICR/Primary Group/ICR Divisions
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radiotherapy Physics Modelling
pubs.organisational-groupICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.organisational-groupICR/Students
pubs.organisational-groupICR/Students/PhD and MPhil
pubs.organisational-groupICR/Students/PhD and MPhil/19/20 Starting Cohort
pubs.organisational-groupICR/Students/PhD and MPhil/20/21 Starting Cohort
pubs.publication-statusPublished online
pubs.publisher-urlhttp://dx.doi.org/10.1016/j.phro.2023.100481
pubs.volume27
icr.researchteamRoyal Marsden Hospital - Sutton
icr.researchteamClinic Acad RT Huddart
icr.researchteamGynaecological Cancer
icr.researchteamRadiother Phys Modelling
dc.contributor.icrauthorAlexander, Sophie
dc.contributor.icrauthorHuddart, Robert
dc.contributor.icrauthorIngle, Manasi
dc.contributor.icrauthorNill, Simeon
dc.contributor.icrauthorHafeez, Shaista
icr.provenanceDeposited by Mr Arek Surman on 2023-09-26. Deposit type is initial. No. of files: 1. Files: Evaluation of non-vendor magnetic resonance imaging sequences for use in bladder cancer magnetic resonance image guided radi.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/